BIO CEO 2022: Trends and Opportunities in Biotechnology Investments
In the midst of the global pandemic, venture funding has continued to reach record-breaking levels. In light of this emerging trend in the investment in biotechnology, the 2022 BIO CEO & Investor Conference began with a panel discussion on the recent data on venture trends and therapeutic and platform areas of growth. Additional investors also provided their outlook of 2022, areas of concern with the public health landscape, and opportunities for the sector.
It's free! Log in now to read
LATEST
Study: Aligning U.S. Drug Prices with Europe Could Reduce American Life Expectancy by Six Months
2025-05-15
Tribal Leaders Warn Senators: Federal Health Funding Cuts Threaten Native American Health.
2025-05-14